Online Program

Return to main conference page

All Times EDT

Friday, September 24
Fri, Sep 24, 2:15 PM - 3:30 PM
Virtual
Recent Development in the Evaluation of COVID-19 Vaccines, Treatments & Tests

Group Testing for SARS-CoV-2 (303553)

*Michael Hudgens, University of North Carolina, Chapel-Hill 

High-throughput molecular testing for SARS-CoV-2 may be enabled by group testing in which pools of specimens are screened, and individual specimens tested only after a pool tests positive. In this presentation we will discuss a model of the efficiency and accuracy of specimen pooling algorithms based on available data on SAR-CoV-2 viral dynamics. For a fixed number of tests, we estimate that programs using group testing could screen 2–20 times as many specimens compared with individual testing, increase the total number of true positive infections identified, and improve the positive predictive value of results. We compare outcomes that may be expected in different testing situations and provide general recommendations for group testing implementation. A free, publicly available Web calculator is provided to help inform laboratory decisions on SARS-CoV-2 pooling algorithms.